As further proof-of principle that activation of ISR through GCN2 is critical to the observed tumor and CAF effect, we treated the cells with HF, a well-known GCN2 activator, in combination with Ref-1 inhibition (Figure 7, Supplementary Figure 7). Here, APEX1 is linked to neoplasm.